CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-02 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +8,202 | 8,202 | ||
| 2020-01-02 | Winter Gregory Paul Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2020-01-02 | Lee Kevin Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +210,000 | 210,000 | ||
| 2020-01-02 | Skynner Michael Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-02 | Kalowski Lee President and CFO | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-02 | Keen Nicholas Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-02 | Jordan Veronica GH Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2020-01-02 | Crockett Nigel Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-02 | Bourque Janice Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2020-01-02 | Bourque Janice Director | Grant or award · Stock Option (right to buy) | +8,202 | 8,202 | ||
| 2020-01-02 | BINGHAM KATE Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2019-12-17 | Jordan Veronica GH Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2019-09-26 | Crockett Nigel Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +107,417 | 107,417 | ||
| 2019-09-26 | Kender Richard N Director | Grant or award · Stock Option (Right to Buy) | +23,798 | 23,798 | ||
| 2019-09-26 | Crockett Nigel Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +152,174 | 152,174 | ||
| 2019-09-26 | Bourque Janice Director | Grant or award · Stock Option (Right to Buy) | +23,798 | 23,798 | ||
| 2019-06-28 | Legault Pierre Director | Grant or award · Stock Option (Right to Buy) | +116,827 | 116,827 | ||
| 2019-06-28 | Lee Kevin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +506,252 | 506,252 | ||
| 2019-06-28 | Skynner Michael Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +183,895 | 183,895 | ||
| 2019-06-28 | Kalowski Lee President and CFO | Grant or award · Stock Option (Right to Buy) | +283,414 | 283,414 |
Page 29 of 34 · 664 trades